Efficacy and Gut Dysbiosis of Gentamicin-Intercalated Smectite as a New Therapeutic Agent against Helicobacter pylori in a Mouse Model

Helicobacter pylori eradication rate with conventional standard therapy is decreasing owing to antibiotic resistance, necessitating novel antibacterial strategies against H. pylori. We evaluated the efficacy of a gentamicin-intercalated smectite hybrid (S-GM)-based treatment and analyzed fecal micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Su Jin, Lee, Kyoung Hwa, Kim, Jie-Hyun, Park, Soon Young, Song, Young Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460432/
https://www.ncbi.nlm.nih.gov/pubmed/32785101
http://dx.doi.org/10.3390/antibiotics9080502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460432/
https://www.ncbi.nlm.nih.gov/pubmed/32785101
http://dx.doi.org/10.3390/antibiotics9080502

Ejemplares similares